A novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition

被引:0
|
作者
Jimenez-Vicente, Carlos [1 ]
Garrote, Marta [2 ,3 ,7 ]
Lopez-Guerra, Monica [2 ,3 ,4 ]
Villamon, Eva [5 ]
Guijarro, Francesca [2 ,3 ]
Perez-Valencia, Amanda Isabel [1 ]
Martinez-Roca, Alexandra [1 ,2 ]
Balaguer, Olga [6 ]
Alvarez-Larran, Alberto [1 ,3 ]
Hernandez-Boluda, Juan Carlos [5 ]
Rovira, Montserrat [1 ,3 ]
Colomer, Dolors [2 ,3 ]
Diaz-Beya, Marina [1 ,2 ,3 ]
Rozman, Maria [2 ]
Esteve, Jordi [1 ,3 ]
机构
[1] Hosp Clin Barcelona, Hematol Dept, Barcelona, Spain
[2] Hosp Clin Barcelona, Pathol Dept, Hematopathol Unit, Barcelona, Spain
[3] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain
[4] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
[5] Univ Valencia, Hosp Clin Univ INCLIVA, Valencia, Spain
[6] Hosp Clin Barcelona, Pathol Dept, Barcelona, Spain
[7] Hosp Clin Barcelona, Pathol Dept, Hematopathol Unit, Villarroel 170, Barcelona 08036, Spain
关键词
TRANSLOCATIONS;
D O I
10.1080/10428194.2023.2295788
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:394 / 398
页数:5
相关论文
共 50 条
  • [31] Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer
    Cole, Claire
    Lau, Sin
    Backen, Alison
    Clamp, Andrew
    Rushton, Graham
    Dive, Caroline
    Hodgkinson, Cassandra
    McVey, Rhona
    Kitchener, Henry
    Jayson, Gordon C.
    CANCER BIOLOGY & THERAPY, 2010, 10 (05) : 495 - 504
  • [32] The power of the partner: defying expectations in a case of a myeloproliferative neoplasm with FGFR1 rearrangement
    Wilberger, Adam C.
    McMahon, Brandon
    Ewalt, Mark D.
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 1095 - 1097
  • [33] Submicroscopic Deletion of FGFR1 Gene Is Recurrently Detected in Myeloid and Lymphoid Neoplasms Associated with ZMYM2-FGFR1 Rearrangements: A Case Study
    Yang, John Jeongseok
    Park, Tae Sung
    Choi, Jong Rak
    Park, Seo-Jin
    Cho, Sun Young
    Jun, Kyung Ran
    Kim, Hye Ran
    Lee, Jeong Nyeo
    Oh, Seung Hwan
    Lee, Sanggyu
    Kim, Bomi
    Marschalek, Rolf
    Meyer, Claus
    ACTA HAEMATOLOGICA, 2012, 127 (02) : 119 - 123
  • [34] DINUCLEOTIDE REPEAT POLYMORPHISM AT THE FGFR1 GENE
    YU, CE
    ANDERSON, L
    OSHIMA, J
    SCHELLENBERG, GD
    HUMAN MOLECULAR GENETICS, 1994, 3 (01) : 212 - 212
  • [35] Myeloid and Lymphoid Neoplasm With Abnormalities of FGFR1 Presenting With Trilineage Blasts and RUNX1 Rearrangement: A Case Report and Review of Literature
    Kumar, Kirthi R.
    Chen, Weina
    Koduru, Prasad R.
    Luu, Hung S.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (05) : 738 - 748
  • [36] Acute myeloid leukemia with LRRFIP1::FGFR1 rearrangement and a complex karyotype
    Qian, You-Wen
    Wang, Eunice S.
    Sait, Sheila Jani
    Glenn, Sean T.
    CANCER GENETICS, 2023, 278 : 50 - 54
  • [37] FGFR1 and FGFR2 gene copy number variations in prostate cancer
    Otte, Marcus
    Kanchev, Ivan
    Sharp, Michael C.
    Alvarez, John
    Winkler, Hans
    Platero, Suso
    CANCER RESEARCH, 2011, 71
  • [38] A Phase 2 Study of Pemigatinib (FIGHT-203; INCB054828) in Patients with Myeloid/Lymphoid Neoplasms (MLNs) with Fibroblast Growth Factor Receptor 1 (FGFR1) Rearrangement (MLN FGFR1)
    Gotlib, Jason
    Kiladjian, Jean-Jacques
    Vannucchi, Alessandro
    Rambaldi, Alessandro
    Reiter, Andreas
    Shomali, William
    George, Tracy I.
    Patel, Jay L.
    Colucci, Philomena
    Walker, Chris
    Zhen, Huiling
    Verstovsek, Srdan
    BLOOD, 2021, 138
  • [39] Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement
    Umino, Kento
    Fujiwara, Shin-ichiro
    Ikeda, Takashi
    Toda, Yumiko
    Ito, Shoko
    Mashima, Kiyomi
    Minakata, Daisuke
    Nakano, Hirofumi
    Yamasaki, Ryoko
    Kawasaki, Yasufumi
    Sugimoto, Miyuki
    Yamamoto, Chihiro
    Ashizawa, Masahiro
    Hatano, Kaoru
    Sato, Kazuya
    Oh, Iekuni
    Ohmine, Ken
    Muroi, Kazuo
    Kanda, Yoshinobu
    HEMATOLOGY, 2018, 23 (08) : 470 - 477
  • [40] Are FGFR1 and FGFR2 Activated By Novel DNAJB1-PRKACA in Fibrolamellar Carcinoma?
    Torbenson, Michael
    Graham, Rondell
    Greipp, Patricia
    Fritcher, Emily Barr
    Kipp, Benjamin
    Garcia, Joaquin
    LABORATORY INVESTIGATION, 2015, 95 : 424A - 425A